Klyx

Docusate Sodium, the active ingredient in Klyx, is a laxative presented as a rectal formulation for rectal use, combined with sorbitol as an osmotic agent. It is intended to relieve occasional constipation by softening stool and facilitating bowel movements in adults and children.

GNH USA supplies Klyx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is manufactured under GMP conditions.

Klyx, containing docusate sodium and sorbitol, is used as a laxative to manage constipation.

- Constipation in adults: softens stool and promotes easier passage. - Constipation in children: provides gentle stool softening suitable for pediatric use. - Functional constipation: helps normalize bowel movements in patients with chronic irregularity.

Klyx may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping: mild discomfort in the lower abdomen. - Rectal irritation: mild burning or itching at the site of administration. - Nausea: occasional feeling of queasiness. - Flatulence: increased gas production. - Diarrhea: loose stools if the dose is excessive. - Mild electrolyte imbalance: slight changes in serum electrolytes.

Serious or Rare Side Effects: - Severe abdominal pain: intense, persistent pain requiring medical attention. - Rectal bleeding: visible blood in stool or on the applicator. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Significant electrolyte disturbances: marked changes in potassium or sodium levels. - Dehydration: excessive fluid loss leading to dizziness or weakness.

Before using Klyx, consider the following safety measures.

- Assess hydration status: ensure adequate fluid intake to support stool softening. - Use with adequate fluid: drink sufficient water to enhance the laxative effect. - Avoid prolonged use: limit use to short‑term periods unless directed by a healthcare professional. - Contraindicated in intestinal obstruction: do not use if there is a known blockage. - Caution in renal impairment: monitor kidney function when using osmotic agents. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Klyx can interact with other agents that affect bowel function or fluid balance.

Major Interactions (Avoid): - Mineral oil: may interfere with stool softening and reduce efficacy. - Magnesium‑containing laxatives: additive osmotic effect can lead to severe electrolyte imbalance.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may diminish bowel motility, reducing laxative effect. - Opioid analgesics: can counteract the stool‑softening action, requiring dose adjustment. - Iron supplements: may increase constipation, necessitating careful monitoring.